The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Braskem S.A. ADR’s stock clocked out at $2.47, down -1.59% from its previous closing price of $2.51. In other words, the price has decreased by -$1.59 from its previous closing price. On the day, 0.97 million shares were traded. BAK stock price reached its highest trading level at $2.505 during the session, while it also had its lowest trading level at $2.455.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BAK now has a Market Capitalization of 1058650048 and an Enterprise Value of 57582104576. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.03. Its current Enterprise Value per Revenue stands at 0.741 whereas that against EBITDA is 23.619.
Stock Price History:
The Beta on a monthly basis for BAK is 1.80, which has changed by -0.66348773 over the last 52 weeks, in comparison to a change of 0.17904854 over the same period for the S&P500. Over the past 52 weeks, BAK has reached a high of $7.56, while it has fallen to a 52-week low of $2.42. The 50-Day Moving Average of the stock is -20.77%, while the 200-Day Moving Average is calculated to be -32.36%.
Shares Statistics:
It appears that BAK traded 1.11M shares on average per day over the past three months and 2016370 shares per day over the past ten days. A total of 172.53M shares are outstanding, with a floating share count of 172.20M. Shares short for BAK as of 1757894400 were 3161073 with a Short Ratio of 2.85, compared to 1755216000 on 3143254. Therefore, it implies a Short% of Shares Outstanding of 3161073 and a Short% of Float of 3.3299996999999997.
Earnings Estimates
As of right now, 2.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is -$0.56, with high estimates of -$0.43 and low estimates of -$0.69.
Analysts are recommending an EPS of between $0.4 and $0.4 for the fiscal current year, implying an average EPS of $0.4. EPS for the following year is -$0.83, with 1.0 analysts recommending between -$0.83 and -$0.83.
Revenue Estimates
In. The current quarter, 3 analysts expect revenue to total $19.13B. It ranges from a high estimate of $19.73B to a low estimate of $18.28B. As of. The current estimate, Braskem S.A. ADR’s year-ago sales were $21.27BFor the next quarter, 3 analysts are estimating revenue of $19.4B. There is a high estimate of $20.18B for the next quarter, whereas the lowest estimate is $17.98B.
A total of 10 analysts have provided revenue estimates for BAK’s current fiscal year. The highest revenue estimate was $80.05B, while the lowest revenue estimate was $72.99B, resulting in an average revenue estimate of $76.17B. In the same quarter a year ago, actual revenue was $77.41BBased on 10 analysts’ estimates, the company’s revenue will be $83.47B in the next fiscal year. The high estimate is $90.67B and the low estimate is $74.62B.
